Research Article

Regulations of Brain Functions by Estrogens

P D Gupta.1 Shrishailappa Badami.2 

• .1Former, Director Grade Scientist, Centre for Cellular and Molecular Biology, Hyderabad 
• .2SDM College of Phamaceutical Sciences, Dharwad, Karnataka 
•  

Correspondence: PD Gupta, Former, Director Grade Scientist, Centre for Cellular and Molecular Biology, Hyderabad, India; Email [email protected] 

Received: February 22, 2024                                                     Published: March 10, 2024 

Citation: Gupta PD. Regulations of Brain Functions by Estrogens. Int J Bio and Med. 2024;1(1):08–12. 

Copyright: ©2024 Gupta. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Abstract 

Oestrogen, the female reproductive hormone has many direct and indirect effects on various body systems. Hence, scientists were interested in understanding the role of oestrogen in many brain functions and related diseases, neuroprotective, cognitive functions, Alzeimer’s disease, Schizophrenia and depression. Though encouraging results were obtained and the data proved that oestrogen has a role in aetiology of these diseases. However, the present evidences do not support its therapeutic usage or as an adjunct therapy in any of these diseases. Hence, further studies are needed to conclude its role in brain disorders. 

Keywords: Oestrogen, Brain functions, Alzeimer’s disease, Schizophrenia and depression

References 

1. Gupta PD. Molecular Biology of steroid and nuclear hormone receptors Ind J Expt. Biol. 1999;37:622. 

2. Shashi Singh, Shaul Philip W, Gupta PD. Conventional oestrogen receptors are found in the plasma membrane of vaginal epithelial cells of the rat. Steroids.2002;67:757-764. 

3. P D Gupta , Kaid Johar Sr, K Nagpal, et al. Sex hormone receptors in the human eye. Surv Ophthalmol. 2005;50:274-284. 

4. Garcia-Segura LM, Balthazart J. Steroids and neuroprotection: New advances. Front Neuroendocrinol 2009;30(2):5-9. 

5. Dubal DB, Wise PM. Oestrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci. 2002;4(2):149-161. 

6. Brann DW, Dhandapani K, Wakade C, et al. Neurotrophic and neuroprotective actions of oestrogen: basic mechanisms and clinical implications. Steroid. 2007;72(5):381-405. 

7. Arroba AI, Campos-Caro A, Aguilar-Diosdado M, et al. IGF-1, Inflammation and Retinal Degeneration: A Close Network. Front Aging Neurosci. 2018;10:203. 

8. Varela-Nieto I, Chowen JA, García-Segura LM. Editorial: Hormones and Neural Aging: Lessons From Experimental Models. Front Aging Neurosci. 2018;10:374. 

9. Lejri I, Grimm A, Eckert A. Mitochondria, Oestrogen and Female Brain Aging. Front Aging Neurosci. 2018;10:124. 

10. Gaignard P, Liere P, Thérond P, et al. Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases. Front Aging Neurosci. 2017;9:406. 

11. Zárate S, Stevnsner T, Gredilla R. Role of Oestrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair. Front Aging Neurosci. 2017;9:430. 

12. Navarro-Pardo E, Holland CA, Cano A. Sex Hormones and Healthy Psychological Aging in Women. Front Aging Neurosci. 2018;9:439. 

13. Rajasundaram S, Rahman RP, Woolf B, et al. Morning Cortisol and Circulating Inflammatory Cytokine Levels: A Mendelian Randomisation Study. Genes (Basel). 2022;13(1):116. 

14. Hara Y, Waters EM, McEwen BS, et al. Oestrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev. 2015;95(3):785-807. 

15. Cappa M, Loche S, Salvatori R, et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991;14(1):41-45. 

16. Epperson CN, Amin Z, Ruparel K, et al. Interactive Effects of Estrogen and Serotonin On Brain Activation During Working Memory and Affective Processing in Menopausal Women, Psychoneuroendocrinology. 2012;37(3):372–382. 

17. Pottoo FH, Javed MN, Barkat MA, et al. Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis. Curr Neuropharmacol. 2019;17(3):214–231. 

18. Picazo O, Azcoitia I, Garcia-Segura L M. Neuroprotective and neurotoxic effects of oestrogens. Brain Research. 2003;990(1–2):20-27. 

19. Kontush A, Berndt C, Weber W, et al. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med. 2001;30(1):119-128. 

20. Sherwin BB. Oestrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988:13: 345–357. 

21. Phillips SM, Sherwin BB. Effects of oestrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485–495. 

22. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn.1990; 14:26–43. 

23. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of oestrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197–1202. 

24. Maki PM, Resnick SM. Longitudinal effects of oestrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging. 2000;21:373–383. 

25. Henderson VW, Paganini-Hill A, Emanuel CK, et al. Oestrogen replacement therapy in older women: comparisons between Alzheimer’s disease cases and nondemented control subjects. Arch Neurol. 1994;51:896–900. 

26. Tang MX, Jacobs D, Stern Y, et al. Effect of ooestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet. 1996;348:429–432. 

27. Liang J, Wang C, Zhang H, et al. Exercise-Induced Benefits for Alzheimer's Disease by Stimulating Mitophagy and Improving Mitochondrial Function. Front Aging Neurosci. 2021;13:755665. 

28. Dluzen DE, McDermott JL, Liu B. Oestrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem.1996;66:658–666. 

29. Hallonquist JD, Seeman MV, Lang M, et al. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry.1993;33:207–209. 

30. Lindamer LA, Lohr JB, Harris MJ, et al. Gender, oestrogen, and schizophrenia, Psychopharmacol Bull. 1997;33:221–228. 

31. Riecher-Rössler A, Häfner H, Dütsch-Strobel A, et al. Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry.1994;36:492–494. 

32. Kulkarni J, Riedel A, de Castella AR, et al. Oestrogen – a potential treatment for schizophrenia. Schizophr Res. 2001;48:137–144. 

33. Epperson CN, Wisner KL, Yamamoto B. Gonadal steroids in the treatment of mood disorders. PsychosomMed. 1999;61:676–697. 

34. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry.1984;144:35–47. 

35. Bebbington PE, Dunn G, Jenkins R, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med. 1998;28:9–19. 

36. Sichel DA, Cohen LS, Robertson LM, et al. Prophylactic oestrogen in recurrent postpartum affective disorder. Biol Psychiatry. 1995;38:814–818. 

37. Gregoire AJP, Kumar R, Everitt B, et al. Transdermal ooestrogen for treatment of severe postnatal depression. Lancet.1996;347:930–933. 

38. Klaiber EL, Broverman DM, Vogel W, et al. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979;36:550–554. 

39. Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry. 1997;5:97–106. 

40. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183:414– 420. 

41. Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo–controlled trial. Arch Gen Psychiatry. 2001;58:529–534.